The estimated Net Worth of Rami Elghandour is at least $611 mil dollars as of 17 September 2018. Rami Elghandour owns over 18,400 units of Nevro Corp stock worth over $610,666 and over the last 10 years Rami sold NVRO stock worth over $0.
Rami has made over 10 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently Rami exercised 18,400 units of NVRO stock worth $66,240 on 17 September 2018.
The largest trade Rami's ever made was exercising 18,400 units of Nevro Corp stock on 17 September 2018 worth over $66,240. On average, Rami trades about 3,716 units every 57 days since 2014. As of 17 September 2018 Rami still owns at least 129,653 units of Nevro Corp stock.
You can see the complete history of Rami Elghandour stock trades at the bottom of the page.
Rami's mailing address filed with the SEC is 1800 Bridge Pkwy, Redwood City, CA 94065, USA.
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo, e& Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
Nevro Corp executives and other stock owners filed with the SEC include: